Catecholamines, hypoxic defence and the neonatal brain.
Karolinska Institute, Neonatal Unit, Astrid Lindgren Children's Hospital, S-171/6 Stockholm, Sweden.
H
H
Lagercrantz
J
J
Peyronnet
S Z
SZ
Yuan
L Q
LQ
Tang
D018674:Adrenergic Antagonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D001238:Asphyxia Neonatorum / Q000517:prevention & control; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002395:Catecholamines / Q000097:blood / Q000502:physiology*; D002976:Clenbuterol / Q000494:pharmacology; D006801:Humans; D020925:Hypoxia-Ischemia, Brain / Q000517:prevention & control*; D007231:Infant, Newborn; D008734:Methoxyhydroxyphenylglycol / Q000378:metabolism
D018674:Adrenergic Antagonists; D000318:Adrenergic beta-Agonists; D002395:Catecholamines; D008734:Methoxyhydroxyphenylglycol; D002976:Clenbuterol